• Users Online: 64890
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Coronavirus Disease 2019–COVID-19
Kuldeep Dhama,Sharun Khan,Ruchi Tiwari,Shubhankar Sircar,Sudipta Bhat,Yashpal Singh Malik,Karam Pal Singh,Wanpen Chaicumpa,D. Katterine Bonilla-Aldana,Alfonso J. Rodriguez-Morales
Clinical Microbiology Reviews.2020;33(4)
[DOI]
2The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)
Mina Ghofrani Nezhad,Giti Jami,Omid Kooshkaki,Sajjad Chamani,Ali Naghizadeh
Journal of Interferon & Cytokine Research.2023;43(4)147
[DOI]
3Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India: Results of a survey
AkshayGopinathan Nair,RashminA Gandhi,Sundaram Natarajan
Indian Journal of Ophthalmology.2020;68(5)725
[DOI]
4100 Days of COVID-19 in India: Current and Future Trends
Sheetal Gouda,G. Naveen,F. Sneha Kukanur
Journal of Pure and Applied Microbiology.2020;14(suppl 1)1043
[DOI]
5Pharmacological treatments of COVID-19
Adeleh Sahebnasagh,Razieh Avan,Fatemeh Saghafi,Mojataba Mojtahedzadeh,Afsaneh Sadremomtaz,Omid Arasteh,Asal Tanzifi,Fatemeh Faramarzi,Reza Negarandeh,Mohammadreza Safdari,Masoud Khataminia,Hassan Rezai Ghaleno,Solomon Habtemariam,Amirhosein Khoshi
Pharmacological Reports.2020;72(6)1446
[DOI]
6Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
Hoda Elkhenany,Shilpi Gupta,Mostafa F. Abdelhai,Jose Luis Turabian
International Journal of Coronaviruses.2021;2(3)23
[DOI]
7In silico identification of potential inhibitors against main protease of SARS-CoV-2 6LU7 from Andrographis panniculata via molecular docking, binding energy calculations and molecular dynamics simulation studies
Mayakrishnan Vijayakumar,Balakarthikeyan Janani,Priya Kannappan,Senthil Renganathan,Sameer Al-Ghamdi,Mohammed Alsaidan,Mohamed A. Abdelaziz,Abubucker Peer Mohideen,Mohammad Shahid,Thiyagarajan Ramesh
Saudi Journal of Biological Sciences.2022;29(1)18
[DOI]
8Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options
Boxuan Huang,Rongsong Ling,Yifan Cheng,Jieqi Wen,Yarong Dai,Wenjie Huang,Siyan Zhang,Xifeng Lu,Yifeng Luo,Yi-Zhou Jiang
Molecular Therapy - Methods & Clinical Development.2020;18(1)367
[DOI]
9Antiretrovirals for Prophylaxis Against COVID-19: A Comprehensive Literature Review
Golbarg Alavian,Kasra Kolahdouzan,Masoud Mortezazadeh,Zahra Sadat Torabi
The Journal of Clinical Pharmacology.2021;61(5)581
[DOI]
10

An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease

Tafere Mulaw Belete
Clinical Pharmacology: Advances and Applications.2020;Volume 12(5)203
[DOI]
11Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda,Qian Yao,Lalitkumar K. Vora,Vasso Apostolopoulos,Chirag A. Patel,Rajashri Bezbaruah,Aayushi B. Patel,Zhe-Sheng Chen
Frontiers in Immunology.2022;13(5)203
[DOI]
12Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes
Emma Kate Zadow,Daniel William Taylor Wundersitz,Diane Louise Hughes,Murray John Adams,Michael Ian Charles Kingsley,Hilary Anne Blacklock,Sam Shi Xuan Wu,Amanda Clare Benson,Frédéric Dutheil,Brett Ashley Gordon
Seminars in Thrombosis and Hemostasis.2020;46(07)807
[DOI]
13Resurgence of “bow and arrow” related ocular trauma: Collateral damage arising from COVID-19 lockdown in India?
ManeeshM Bapaye,AkshayGopinathan Nair,PankajP Mangulkar,CharutaM Bapaye,MeenaM Bapaye
Indian Journal of Ophthalmology.2020;68(6)1222
[DOI]
14Effects of Plant Metabolites on the Growth of COVID-19 (Coronavirus Disease-19) Including Omicron Strain
Hiroj Bagde,Ashwini Dhopte
Cureus.2022;68(6)1222
[DOI]
15Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations
Mohamed Hagar,Hoda A. Ahmed,Ghadah Aljohani,Omaima A. Alhaddad
International Journal of Molecular Sciences.2020;21(11)3922
[DOI]
16Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2
Susana A. Llivisaca-Contreras,Jaime Naranjo-Morán,Andrea Pino-Acosta,Luc Pieters,Wim Vanden Berghe,Patricia Manzano,Jeffrey Vargas-Pérez,Fabian León-Tamariz,Juan M. Cevallos-Cevallos
Molecules.2021;26(13)4099
[DOI]
17What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic?
Rohit Shetty,Sharon D'Souza,VaitheeswaranGanesan Lalgudi
Indian Journal of Ophthalmology.2020;68(5)683
[DOI]
18Target prediction, computational identification, and network-based pharmacology of most potential phytoconstituent in medicinal leaves of Justicia adhatoda against SARS-CoV-2
Pankaj Dagur,Gourav Rakshit,Murtuja Sheikh,Abanish Biswas,Parineeta Jha,Khattab Al-Khafaji,Manik Ghosh
Journal of Biomolecular Structure and Dynamics.2023;41(9)3926
[DOI]
19Development of Electromobility in European Union Countries under COVID-19 Conditions
Tomasz Rokicki,Piotr Bórawski,Aneta Beldycka-Bórawska,Agata Zak,Grzegorz Koszela
Energies.2021;15(1)9
[DOI]
20Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
Loubna Mazini,Mohamed Ezzoubi,Gabriel Malka
Stem Cell Research & Therapy.2021;12(1)9
[DOI]
21Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Farhana Rumzum Bhuiyan,Sabbir Howlader,Topu Raihan,Mahmudul Hasan
Frontiers in Medicine.2020;7(1)9
[DOI]
22Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Devasena T.
Frontiers in Medicine.2021;7(1)71
[DOI]
23Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Arup K. Kabi,Maynak Pal,Raghuram Gujjarappa,Chandi C. Malakar,Mithun Roy
Journal of Heterocyclic Chemistry.2023;60(2)165
[DOI]
24Synthesis of new 3-(hydroxymethyl)-2-phenyl-2,3 dihydroquinolinone and in-silico evaluation of COVID-19 main protease inhibitor
Amaladoss Nepolraj,Vasyl I Shupeniuk,Manisekar Sathiyaseelan,Nagamuthu Prakash
Vietnam Journal of Chemistry.2021;59(4)511
[DOI]
25The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions
Aboagye Kwarteng Dofuor,Naa Kwarley-Aba Quartey,Angelina Fathia Osabutey,Belinda Obenewa Boateng,Hanif Lutuf,Joseph Harold Nyarko Osei,Selina Mawunyo Ayivi-Tosuh,Albert Fynn Aiduenu,William Ekloh,Seyram Kofi Loh,Maxwell Jnr Opoku,Owusu Fordjour Aidoo
Clinical Pathology.2023;16(4)511
[DOI]
26Synthesis, spectroscopic, and computational studies on molecular charge-transfer complex of 2-((2-hydroxybenzylidene) amino)-2-(hydroxymethyl) propane-1, 3-diol with chloranilic acid: Potential antiviral activity simulation of CT-complex against SARS-CoV-2
Tarek E. Khalil,Hemmat A. Elbadawy,Asmaa A. Attia,Doaa S. El-Sayed
Journal of Molecular Structure.2022;1251(4)132010
[DOI]
27Efficacy of colchicine treatment in COVID-19 patients: A case-control study
Ahmet DOGAN,Taliha KARAKÖK,Yakup GEZER
Archives of Clinical and Experimental Medicine.2022;7(1)11
[DOI]
28Efficacy of colchicine treatment in COVID-19 patients: A case-control study
Devasena T.
Archives of Clinical and Experimental Medicine.2021;7(1)31
[DOI]
29Interleukin-1in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective
Amirhossein Mardi,Sepideh Meidaninikjeh,Sepideh Nikfarjam,Naime Majidi Zolbanin,Reza Jafari
Viral Immunology.2021;34(10)679
[DOI]
30SARS-COV-2 and COVID-19: A Global Pandemic
Viswanath Vittaladevaram,Kranthi Kuruti,Sudheer Venkatesh Urity
Biosciences Biotechnology Research Asia.2021;18(2)385
[DOI]
31Potential Using of Fat-derived Stromal Cells in the Treatment of Active Disease, and also, in Both Pre- and Post-Periods in COVID-19
Hasim Eray Copcu
Aging and disease.2020;11(4)730
[DOI]
32SARS-CoV-2 variants and vulnerability at the global level
Vivek P. Chavda,Aayushi B. Patel,Darsh D. Vaghasiya
Journal of Medical Virology.2022;94(7)2986
[DOI]
33An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
Padmalochan Hembram
Bulletin of the National Research Centre.2021;45(1)2986
[DOI]
34Commentary: What happens after the lockdown?
Chaitra Jayadev,Rohit Shetty
Indian Journal of Ophthalmology.2020;68(5)730
[DOI]
35Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19?
José M. Pérez de la Lastra,Victoria Baca-González,Patricia Asensio-Calavia,Sergio González-Acosta,Antonio Morales-delaNuez
Vaccines.2020;8(3)486
[DOI]
36Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update
Qazi Mohammad Sajid Jamal
International Journal of Molecular Sciences.2022;23(21)13564
[DOI]
37Antibody Response to Severe Acute Respiratory Syndrome- Corona Virus 2, Diagnostic and Therapeutic Implications
Yuval Ishay,Asa Kessler,Asaf Schwarts,Yaron Ilan
Hepatology Communications.2020;4(12)1731
[DOI]
38Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients
Behnam Hashemi,Firouzi-Amandi Akram,Halimeh Amirazad,Mehdi Dadashpour,Milad Sheervalilou,Davood Nasrabadi,Majid Ahmadi,Roghayeh Sheervalilou,Mahdieh Ameri Shah Reza,Farhood Ghazi,Leila Roshangar
Journal of Drug Delivery Science and Technology.2022;67(12)102967
[DOI]
39Nanoformulation of Glycyrrhizic Acid as a Potent Antiviral Agent Against Covid-19
Sayani Ghosh,Prasun Patra
Current Applied Materials.2022;1(1)102967
[DOI]
40In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease
Piyush Kashyap,Mamta Thakur,Nidhi Singh,Deep Shikha,Shiv Kumar,Poonam Baniwal,Yogender Singh Yadav,Minaxi Sharma,Kandi Sridhar,Baskaran Stephen Inbaraj
Molecules.2022;27(19)6374
[DOI]
41New normal: two aspects of adipose tissue in COVID-19—treat and threat?
H. Eray Copcu
Expert Opinion on Biological Therapy.2020;20(11)1283
[DOI]
42Modelling of the Explanatory Factors of the Number of COVID-19 Deaths for a Panel of Countries
Abdessamad Ouchen,Hamid Akdim
Journal of Health Management.2023;20(11)1283
[DOI]
43New Concept of Ocular Implications in COVID-19 Infection: A Brief Review
Apen Hoddor Silaban
European Journal of Medical and Health Sciences.2021;3(1)1
[DOI]
44Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
Mehdi Shahgolzari,Afagh Yavari,Yaser Arjeini,Seyed Mohammad Miri,Amirhossein Darabi,Amir Sasan Mozaffari Nejad,Mohsen Keshavarz
Gene Reports.2021;25(1)101417
[DOI]
45Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review
C. S. Sharanya,A. Sabu,M. Haridas
Future Journal of Pharmaceutical Sciences.2021;7(1)101417
[DOI]
46Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
Vineela Parvathaneni,Vivek Gupta
Life Sciences.2020;259(1)118275
[DOI]
47The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
Mahda Delshad,Naeimeh Tavakolinia,Atieh Pourbagheri-Sigaroodi,Ava Safaroghli-Azar,Nader Bagheri,Davood Bashash
International Immunopharmacology.2021;95(1)107586
[DOI]
48The impact of COVID-19 related national lockdown on ophthalmic emergency in Italy: A multicenter study
Maria L Salvetat,Carlo Salati,Patrizia Busatto,Marco Zeppieri
European Journal of Ophthalmology.2022;32(3)1782
[DOI]
49Epidemic Keratoconjunctivitis in India: Trend Analysis and Implications for Viral Outbreaks
AnthonyV Das,Sayan Basu
Indian Journal of Ophthalmology.2020;68(5)732
[DOI]
50Stem cell therapy in coronavirus disease 2019: current evidence and future potential
Rohit Shetty,Ponnalagu Murugeswari,Koushik Chakrabarty,Chaitra Jayadev,Himanshu Matalia,Arkasubhra Ghosh,Debashish Das
Cytotherapy.2021;23(6)471
[DOI]
51Characterisation of current pharmacotherapeutic COVID-19 clinical trials in India: A registry-based descriptive analysis
Arkapal Bandyopadhyay,Chahat Choudhary,Akash Agnihotri,Shailendra Handu
Indian Journal of Physiology and Pharmacology.2021;65(6)141
[DOI]
52Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications
Pulok K Mukherjee,Thomas Efferth,Bhaskar Das,Amit Kar,Suparna Ghosh,Seha Singha,Pradip Debnath,Nanaocha Sharma,Pardeep Kumar Bhardwaj,Pallab Kanti Haldar
Phytomedicine.2022;98(6)153930
[DOI]
53Identification of natural peptides from “PlantPepDB” database as anti-SARS-CoV-2 agents: A protein-protein docking approach
Priyanka Bhandu,Himanshu Verma,Baddipadige Raju,Gera Narendra,Shalki Choudhary,Manmeet Singh,Pankaj Kumar Singh,Om Silakari
Phytomedicine Plus.2023;3(2)100446
[DOI]
54Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Mehdi Rasouli,Fatemeh Vakilian,Javad Ranjbari
Current Stem Cell Research & Therapy.2022;17(2)166
[DOI]
55Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Ismail Badshah,Atifa Mustaq,Sohiab Zafar Malik,Samane Jahanabadi,Muhammad Imran Khan
Current Stem Cell Research & Therapy.2023;17(2)199
[DOI]
56Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
Daniel Zhao,Sandy Zhang,Teryn Igawa,William Frishman
Cardiology in Review.2020;28(6)303
[DOI]
57Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options
Gashaw Dessie,Tabarak Malik
Infection and Drug Resistance.2021;Volume 14(6)1883
[DOI]
58Understanding COVID-19: From Origin to Potential Therapeutics
Muhammad Moazzam,Muhammad Imran Sajid,Hamza Shahid,Jahanzaib Butt,Irfan Bashir,Muhammad Jamshaid,Amir Nasrolahi Shirazi,Rakesh Kumar Tiwari
International Journal of Environmental Research and Public Health.2020;17(16)5904
[DOI]
59Molecular docking and molecular dynamic simulation-based phytoconstituents against SARS-CoV-2 with dual inhibition of the primary protease targets
Sachin A. Dhawale,Sadhana Mahajan,Madhuri Pandit,Sachin Gawale,Mangesh Ghodke,Ganesh Tapadiya
Natural Product Research.2024;17(16)1
[DOI]
60Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review
Pratyay Kumar Pahari,Sonal Vyas,Shahbaz Aman,Uday Singh,Kusheswar Prasad Singh,Rohit Tiwari,Meenakshi Dhanawat
Coronaviruses.2022;3(2)1
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal